Hepatic Encephalopathy Grading
Hepatic encephalopathy is a potentially reversible syndrome of impaired brain function associated with advanced liver disease and portal-systemic shunting. Clinical manifestations range from subtle changes in attention to confusion, somnolence and coma. A grading scale describes observed severity but cannot establish that liver disease is the sole cause of altered consciousness. This educational account reviews the West Haven clinical framework, competing diagnoses and precipitating factors, reflecting AASLD/EASL and EASL guidance. It deliberately separates bedside description from treatment decisions that require specialist oversight.
Assessment framework and key clinical distinctions
In hepatic encephalopathy assessment, the observed changes in attention, orientation, behaviour and consciousness should be documented before assigning a West Haven description. This is because cognitive change in cirrhosis is not specific to one mechanism: sepsis, gastrointestinal bleeding, medication effects, electrolyte disturbance and neurological disease can resemble or precipitate encephalopathy. The grade helps communicate severity, but safe treatment planning requires investigation of precipitants and attention to airway protection and function after the apparent episode resolves.
Clinical information and initial assessment
Baseline cognition
A family member may recognise slowed thinking, personality change or impaired day-to-day function before an isolated clinical examination appears abnormal. Sleep disruption, anxiety, depression and medications can produce similar reports, so baseline comparison is essential. Record specific examples of change in tasks, conversation and independence rather than general labels.
West Haven descriptions
The West Haven framework grades overt hepatic encephalopathy by changes in behaviour, orientation, consciousness and motor findings. There is interobserver variation, particularly in milder grades, and the scale is not interchangeable with a formal coma score. State the observations that support the grade and repeat assessment when the condition changes.
Covert impairment
Minimal or covert encephalopathy may affect attention, psychomotor speed and functioning despite lack of dramatic bedside disorientation. Formal tests require appropriate validated methods and consideration of education, language and other causes of poor performance. Avoid inferring covert encephalopathy from a single subjective complaint or one generic cognitive screen.
Disorientation
Disorientation to time, place or situation represents a more conspicuous cognitive change that can affect safety. Delirium from infection, medications or metabolic causes may appear identical; the clinical diagnosis remains differential. Record level of orientation explicitly, consciousness and fluctuation over the day.
Asterixis
Asterixis is a brief lapse of sustained muscle contraction often elicited with arms outstretched and wrists extended. It is not specific to liver disease and can occur in other toxic-metabolic encephalopathies including hypercapnia and renal failure. Document whether it was actually observed rather than assuming its presence from a diagnostic label.
Physiology and interpretation
Ammonia testing
Raised ammonia may support pathophysiological discussion but is not a stand-alone diagnostic or severity test for hepatic encephalopathy. Normal or unexpected results must be reconciled with examination, sampling quality and alternative causes; values do not map cleanly to individual clinical grade. Do not use a single ammonia number to determine discharge or escalation in isolation.
Gastrointestinal bleeding
Upper gastrointestinal bleeding can precipitate encephalopathy by increasing gut nitrogen load and physiological stress. Melena, haematemesis, anaemia and shock require their own urgent assessment; mental-state change may distract from ongoing bleeding. Ask about stool colour and vomiting blood, check haemodynamics and follow bleeding protocols.
Infection triggers
Spontaneous bacterial peritonitis, pneumonia, urinary infection and other infections can precipitate or mimic encephalopathy. Fever may be absent in frail or immunocompromised people, and sepsis can cause delirium independently of liver disease. Seek infection evidence from history, examination and appropriate investigations rather than attributing all confusion to ammonia.
Constipation
Reduced bowel movements may contribute to encephalopathy through altered intestinal transit in susceptible patients. Constipation can also result from poor intake, immobility and medication effects and is one component of a broader precipitant search. Document bowel pattern and associated symptoms as part of the treatment history.
Diuretics and volume status
Overdiuresis or volume depletion can worsen renal function, electrolyte disturbances and cognitive status in cirrhosis. Conversely fluid overload and ascites complicate simplistic advice about withholding or giving fluid. Review body weight, intake, urine output, blood pressure, creatinine and prescribed diuretics with the specialist team.
Differential diagnosis and confounding
Hyponatraemia
Low serum sodium may contribute to cerebral dysfunction and can coexist with hepatic encephalopathy. Symptoms of hyponatraemia and liver-related confusion overlap, while rapid correction of chronic sodium disorders can itself cause neurological harm. Investigate electrolytes and defer correction strategy to appropriately monitored guidance.
Renal dysfunction
Acute kidney injury, hepatorenal physiology and other renal disorders can amplify toxic-metabolic disturbances in liver disease. Rising creatinine may be relatively subtle in people with reduced muscle mass despite substantial renal dysfunction. Trend renal measurements, medications and urine findings with the overall deterioration.
Sedative medication
Benzodiazepines, opioids and other sedating medicines may worsen attention or consciousness in patients with hepatic impairment. Drug accumulation and altered clearance can blur the distinction between medication toxicity and liver-related encephalopathy. Document recent prescribing, over-the-counter agents and administration times.
Alcohol and withdrawal
Current alcohol intoxication, withdrawal and nutritional deficiency are important alternatives or coexisting contributors to confusion. Withdrawal-associated agitation and seizures may require different immediate management from asterixis and progressive somnolence. Take a careful history without assuming alcohol use or making it the explanation for all symptoms.
Intracranial pathology
New focal signs, trauma, headache or anticoagulation raise concern for intracranial bleeding or stroke in a person with cirrhosis. Coagulopathy, falls and thrombocytopenia can increase complexity; known liver disease must not delay neurological investigation. Use the acute neurological pathway when examination or history suggests a separate brain event.
Monitoring, escalation and continuity
Airway protection
Severely impaired consciousness poses aspiration and airway risks regardless of the presumed cause of encephalopathy. A patient cannot be considered safe simply because a diagnostic label is familiar; vomiting, haemorrhage and sedation increase hazards. Assess protective reflexes and monitoring needs urgently with an appropriately trained team.
Lactulose context
Non-absorbable disaccharides are used in established treatment pathways, with dose adjustment linked to clinical response and bowel output. Overtreatment can cause dehydration and electrolyte abnormalities, potentially worsening the clinical picture. Medication prescribing and adjustments require local protocols, supervision and monitoring.
Rifaximin context
Rifaximin may be considered in defined clinical settings, often related to recurrence prevention alongside other treatment. It is not a substitute for evaluating infection, bleeding, dehydration or other precipitants, and access varies across systems. Describe prevention strategies in specialist context rather than proposing an unsupervised prescription.
Nutrition and muscle
Cirrhosis commonly involves malnutrition and sarcopenia, factors relevant to ammonia metabolism and long-term function. Blanket protein restriction can be harmful; nutrition plans should distinguish acute safety considerations from chronic requirements. Involve dietetic and specialist teams where frailty, poor intake or recurrent episodes complicate care.
Discharge and recurrence
Recurrent encephalopathy may impair medication management, driving, work and ability to recognise deterioration. Improvement during a single admission does not guarantee that precipitants, social support and follow-up are resolved. Document caregiver education, triggers to seek urgent help and a clear specialist follow-up pathway.
Deeper clinical reasoning and practical boundaries
The grade describes function, not the cause
A West Haven grade is a shorthand for an observed state of attention, orientation, behaviour and consciousness in a patient with suspected hepatic encephalopathy. It is not a laboratory diagnosis and does not prove that liver-related processes caused the change. Patients with cirrhosis also develop stroke, sepsis, intoxication, hypoglycaemia, electrolyte imbalance and medication adverse effects. Distinguishing these matters because treatment priorities differ and several may coexist. A sound explanation always records the behaviours behind the grade and the alternative diagnoses considered. Where clinical state changes rapidly, a static grade written hours earlier may no longer capture the need for airway assessment or urgent investigation.
The distinction between subtle and overt impairment
A person may have poor concentration, disrupted sleep or difficulty completing familiar tasks without conspicuous disorientation. These symptoms are common and not exclusive to encephalopathy. Formal psychometric or neurophysiological methods may be useful for selected patients but depend on appropriate norms and expertise. In overt disease, disorientation, asterixis, somnolence or coma are more clearly recognisable. The transition is not a precise boundary and interobserver variation is important. A practical article should explain that lower-grade descriptions are vulnerable to differences in language, education, baseline cognition and concurrent illness. Caregiver observations can be valuable, particularly when an examiner has no previous knowledge of the patient's usual function.
Ammonia is one part of a complex system
Hyperammonaemia contributes to encephalopathy physiology but measurement is affected by sampling and processing and does not give a universally reliable clinical severity score. An elevated result does not by itself distinguish hepatic encephalopathy from other causes of confusion, nor does a particular value determine readiness for discharge. It is more useful to consider the hepatic history, neurological observations and possible precipitants. A patient with severe altered consciousness needs emergency assessment even when ammonia testing is pending or equivocal. This is a crucial contrast between a biochemical marker and a bedside syndrome. No calculator should label the patient safe based on ammonia falling alone.
Searching for precipitants in parallel
Infection, gastrointestinal bleeding, renal impairment, constipation, dehydration and changes in sedating medicines are common contributors to deterioration in established cirrhosis. A clinician should evaluate these in parallel rather than simply document a likely encephalopathy recurrence. Urine and blood studies, a bleeding history, examination of the abdomen and review of prescribed drugs may all be relevant, tailored to the patient. The absence of fever is not a guarantee that infection is absent. Several triggers can interact: diuretic-related volume loss may alter renal function while infection causes delirium. The most effective management plan will address the physiological disturbance and its source rather than only the visible confusion.
Distinguishing encephalopathy from delirium
Delirium is a descriptive syndrome of acute disturbance of attention and awareness with multiple causes. Hepatic encephalopathy is one potential contributor, and the labels should not be treated as mutually exclusive or equivalent. Sleep-wake disturbance, disorientation and fluctuating cognition may occur in both. Specific focal neurological signs or new headache should prompt consideration of intracranial pathology. Blood glucose, electrolytes, medications and infection review are relevant to all patients with acute mental-state change. A clear guide should teach what evidence supports the liver-related component and what has been done to exclude time-critical competing diagnoses, not portray asterixis as the sole determining sign.
Nutritional status and long-term vulnerability
Malnutrition and muscle loss are common in advanced liver disease and can impair resilience during infection or hospitalisation. Muscle participates in ammonia handling and physical deconditioning affects daily function. Historical advice to restrict protein broadly is not a safe universal strategy. Nutrition plans should be individualized, with appropriate dietetic and specialist advice. Recurrent encephalopathy can also affect safe driving, working, medication use and the ability to recognise worsening symptoms. The clinical concept extends beyond an episode of confusion to understanding the patient's capacity, support network and baseline quality of life. Family or carers may need education and a clear contact pathway, subject to consent and confidentiality.
Understanding treatment without prescribing it
Established specialist pathways may use non-absorbable disaccharides and, in defined situations, rifaximin, while simultaneously treating precipitants. Their role should be explained without converting an educational article into an unsupervised dosing protocol. Too much laxative effect can worsen dehydration or electrolyte problems, while insufficient follow-through may permit recurrence. Airway, bleeding, sepsis and neurological priorities take precedence when severe deterioration occurs. The relevant treatment question is not merely whether a medicine appears on the list, but whether the diagnosis, bowel and fluid state, renal function, precipitant and treatment response have been reviewed. The guide should direct prescribing decisions to current specialist recommendations.
What should be documented at discharge
A discharge plan needs more than 'encephalopathy resolved'. Describe the current orientation and function, the most likely cause or triggers, treatment changes, and whether infection, bleeding or renal deterioration was addressed. Include nutrition needs, bowel and fluid plan, medicine reconciliation and who will review recurrent symptoms. Some patients improve enough to answer questions but cannot manage daily medicines independently. Record support arrangements and follow-up with liver services. The patient and carers should know what confusion, reduced alertness or bleeding features require urgent help. This explicit safety planning is more clinically valuable than focusing on whether the highest recorded West Haven grade has changed by one category.
Additional interpretation questions
A grade without observations is weak
Writing 'West Haven grade II' without the patient's actual orientation, behaviour, attention and consciousness makes it difficult to compare subsequent examinations. The scale is a communication aid and includes subjective judgement, especially at the mild end. Record what the patient could or could not do at a specific time. When the mental state changes, repeat the description rather than assume the old category remains current.
What caregivers may detect
A partner may notice that the patient is sleeping during the day, making unusual financial mistakes or becoming less able to follow conversation. These changes are important but nonspecific. Ask for examples and a timeline, and investigate mood, medications, sleep, infection and other causes as well. Family observations can improve baseline comparison when used respectfully and with appropriate consent, especially when a patient has difficulty recognising their own impairment.
Infection without an obvious fever
Cirrhosis can complicate the clinical appearance of infection. A patient with new confusion may have urinary, pulmonary or abdominal infection even without a dramatic temperature rise. The search for precipitants should include examination and appropriate investigations. Do not use an elevated ammonia result as a reason to stop looking for sepsis, and do not delay urgent care when physiological instability is present.
Bleeding as a precipitant and emergency
Melena, haematemesis, pallor or circulatory compromise in a person with liver disease can indicate gastrointestinal bleeding that both threatens circulation and may contribute to encephalopathy. The investigation and resuscitation priorities belong to an emergency bleeding pathway. A severity score for mental state does not assess bleeding volume. This distinction matters when clinicians might otherwise attribute every symptom to a previous familiar episode of confusion.
Recognising medication accumulation
Benzodiazepines, opioids and other centrally acting medicines may have prolonged or altered effects in advanced liver disease. Recent dose changes, dispensing records and use of non-prescribed agents are therefore relevant. A drug-related decline can mimic or exacerbate encephalopathy. The clinician should avoid using a single diagnostic label to justify ignoring medication exposure and should seek advice before making high-stakes treatment changes.
Ammonia and cognitive severity
Ammonia concentration varies with sample handling and does not provide a universally reliable mapping to bedside impairment. Severe altered consciousness requires urgent assessment regardless of whether an ammonia result is available. A patient who improves clinically may still have an abnormal laboratory value. This is why grading should follow observed neurological function and the clinical course, not a laboratory threshold as an automatic marker of recovery.
Mixed causes of mental-state change
A patient with cirrhosis may also have renal failure, low sodium, dehydration, stroke or alcohol withdrawal. Several of these processes can be present simultaneously. If a focal deficit, new severe headache or trauma exists, a neurological diagnosis must be considered promptly. The guide should teach that 'hepatic encephalopathy' is not a licence to skip the differential diagnosis of acute confusion.
Function after apparent recovery
A person may answer questions appropriately yet remain unable to manage medicines or finances. Recovery assessment needs attention to executive function, support at home and the risk of recurrence. Caregiver education and a clear contact pathway can reduce avoidable delay if confusion returns. Discharge should not be determined by normal conversation alone, especially when baseline function and the cause of the episode remain uncertain.
Nutrition is a clinical priority
Sarcopenia and malnutrition can reduce resilience in chronic liver disease and may affect long-term health. Blanket restriction of protein is not an appropriate general teaching point. Dietetic input can help balance nutritional requirements, symptoms and comorbidity. This subject is distinct from the immediate choice of a bowel-regulating treatment during an overt episode. Educational articles should clarify the difference between acute management and sustained nutrition support.
Understanding bowel-directed therapies
Lactulose and other treatment approaches are used under clinical protocols, but dose and tolerance should be monitored with fluid status and electrolytes. Excess gastrointestinal losses can create further difficulties in someone vulnerable to renal injury. Drug use does not replace identification of infection, bleeding or constipation as a precipitant. Clear follow-up ensures that prescribed treatment is practical and adverse effects are recognised promptly.
Why previous episodes do not settle a new one
A patient who has previously had hepatic encephalopathy can develop a different cause of confusion on a later admission. Similar outward behaviour is not proof of the same mechanism. Compare recent medicines, observations and new focal findings and investigate appropriately. A familiar diagnosis should generate a differential, not close it. This is a key safety message for all educational discussions of recurrent neurological syndromes.
Continuity between liver services and carers
Recurrent episodes may involve primary care, emergency teams, liver specialists, dietitians and family members. A consistent plan should explain current medicines, precipitant risks, follow-up tests and warning signs. If the patient lacks capacity during illness, appropriate communication arrangements become especially important. The aim is to avoid contradictory instructions and gaps in responsibility after a complex admission.
Illustrative clinical situations
Clinical situation 1
A person with cirrhosis is newly disoriented after several days of constipation and reduced fluid intake. Hepatic encephalopathy is possible, but the assessment must also address infection, renal function, medication changes and neurological signs. The useful description includes orientation and level of consciousness, not just a West Haven label.
Clinical situation 2
A patient with advanced liver disease develops confusion and black stools. Do not dismiss the change as another usual episode of encephalopathy. Potential gastrointestinal bleeding requires urgent evaluation while precipitating factors and the patient's airway and perfusion are assessed.
Clinical situation 3
Someone has chronic mild memory complaints and asterixis is not observed. This does not establish or exclude covert encephalopathy. Review formal cognitive testing options, medication effects, sleep, mood and occupational or daily-function consequences.
Clinical situation 4
Following treatment for an episode of overt encephalopathy, a patient is more alert but remains unable to organise medication and meals. Discharge safety depends on functioning, caregiver support, bowel and fluid plans and recurrence prevention, not a normalised laboratory value alone.
Integrated clinical interpretation
A practical review of possible hepatic encephalopathy should produce two parallel outputs: an observed neurological description and a differential with potential precipitants. The first states orientation, attention, behaviour, consciousness and any observed asterixis, with an approximate clinical grade only where appropriate. The second looks for infection, gastrointestinal bleeding, altered medicines, renal impairment, disturbed electrolytes and other neurological causes. A person can have hepatic encephalopathy and another condition simultaneously, which is why a high ammonia level or a history of similar episodes cannot settle the diagnosis. Acute changes in airway protection and consciousness require prompt escalation regardless of proposed grade. The education article should also clarify that recovery is functional, not solely numerical. A patient who can answer basic questions may still struggle with medication management, driving or detecting recurrence. Treatment plans must consider nutrition, bowel and fluid status, caregiver involvement and specialist follow-up. Recurrent admissions may be prevented only when the precipitant and the practical difficulties of the person's daily life are addressed. The most useful clinical output is therefore not a label alone, but a shared plan with clear responsibility for investigation, monitoring and communication.
Additional clinical synthesis
A useful way to review treatment response is to compare actual abilities rather than simply change the grade label. Is the person now orientated to place and time, able to hold attention, eat safely and participate in a conversation? Can they protect the airway and engage with treatment? What is the bowel output and fluid state during treatment, and have the suspected precipitants improved? Recurrent encephalopathy has an important functional impact, including missed medicines, falls and reduced independence. A professional guide can describe these measures without claiming that a particular drug dose, ammonia level or West Haven category alone establishes recovery. The goal is clear communication of neurological function together with an appropriately documented follow-up plan.
Reference sources and scope
AASLD and EASL practice materials describe hepatic encephalopathy definitions, grading limitations and approaches to diagnosis and management in chronic liver disease. The NHS cirrhosis resource gives a patient-facing description of serious complications, including new confusion and bleeding. Together they frame both specialist interpretation and understandable safety advice. Older guideline editions may be superseded by later updates; confirm the applicable version when using recommendations. The presence of listed links does not itself certify a clinical assessment.